Case series reports tailored botulinum toxin A regimens improve pain and functional recovery in post-stroke spasticity, highlighting the value of stage-specific treatment.
Key Points
To assess the value of stage-specific, individualized botulinum toxin A dosing and functional evaluation strategies across varying severities of post-stroke spasticity.
Evaluated four clinical cases with post-stroke spasticity spanning Modified Ashworth Scale (MAS) grades 1+ to 4 with distinct motor control and symptom progression profiles.
Administered customized botulinum toxin A (BoNT-A) injections combined with conservative rehabilitation, dynamically tracking progress with case-appropriate functional scales.
Repeated BoNT-A injections in severe spasticity provided sustained limb pain relief and mitigated periarticular tissue damage.
Mild spasticity with preserved motor control achieved substantial functional recovery, allowing progressively lower BoNT-A doses and injection intervals exceeding three months.